Healthcare Global Enterprises Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹8,745 Cr
- P/E
- 181.50
- ROE
- 2.54%
- PEG
- -126.05
- Price to sales
- 3.32
- Debt to equity
- 1.30
- 52W high / low
- ₹767 / ₹522
- Sales growth (5Y)
- 20.26%
- EBITDA margin
- 18.28%
- Net profit margin
- 1.87%
- Promoter holding
- 64.21%
- Sales (last year)
- ₹2,627 Cr
Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]
Guidance scorecard · Q1 FY27 call
What Healthcare Global Enterprises Ltd's management guided
and where it ranks in Healthcare Services
Healthcare Services
RevenueQ1 FY27 call
10–20%- Confident in delivering mid-teens revenue growth from existing centers and new greenfield and brownfield expansions.
- Expect 11% year-on-year volume growth, supported by strong patient demand.
- Planned addition of 65 beds in FY27, 520 beds in FY28 and FY29, and 230 beds in FY30 to drive capacity expansion.
- Growth to be broad-based with increased utilization and ramp-up of new facilities like North Bangalore hospital.
- Anticipate steady improvement in payor mix, case mix complexity, and clinical capabilities supporting revenue quality.
- ARPP growth expected in line with inflation (~2%).
- Strategic focus on more complex clinical work and enhanced patient experience likely to support sustainable top-line momentum.
2 more points from Healthcare Global Enterprises Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
Up 2%+See what Healthcare Global Enterprises Ltd said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- Q1 Capex incurred: Approximately INR 75 crore (INR 35 crore growth capex + INR 40 crore maintenance capex).
- Full-year maintenance capex expected: Approximately INR 100 crore.
- Proceeds from rights issue used partially for debt repayment (INR 170 crore) and corporate purposes.
FundraisingQ1 FY27 call
PlannedSee what Healthcare Global Enterprises Ltd said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
- Capacity expansions planned: 65 beds in FY27, 520 beds in FY28 and FY29, and 230 beds in FY30.
- Three greenfield projects are in the pipeline, with further details to be shared once finalized.
- Brownfield expansions constitute nearly 60% of planned capacity growth.
- Focus on improving payor mix, clinical complexity, and margin expansion over next 4-5 years.
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Healthcare Services companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹903 Cr | — | |
| 2 | 40%+ | Flat | ₹583 Cr | 22.2 | |
| 3 | Aster DM Quality Care Ltd | 20–40% | Up 2%+ | ₹58,782 Cr | 162.9 |
| 4 | 20–40% | Up 0–2% | ₹1,730 Cr | 17.5 | |
| 5 | 20–40% | Up 0–2% | ₹580 Cr | 11.9 | |
| 6 | 20–40% | Flat | ₹1.13L Cr | 53.9 |
Sign up free to see every company in the sector ranking and track Healthcare Global Enterprises Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services rankingFinancials of Healthcare Global Enterprises Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Healthcare Global Enterprises Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 441.71 | 460.68 | 486.94 | 469.87 | 494.63 | 525.58 | 553.54 | 558.57 | 585.16 | 613.16 | 646.85 | 633.07 | 652.33 |
| Expenses + | 365.40 | 386.37 | 402.32 | 391.26 | 402.60 | 434.68 | 451.30 | 470.19 | 479.53 | 505.37 | 523.54 | 523.51 | 527.25 |
| Operating Profit | 76.31 | 74.31 | 84.62 | 78.61 | 92.03 | 90.90 | 102.24 | 88.38 | 105.63 | 107.79 | 123.31 | 109.56 | 125.08 |
| OPM % | 17.28% | 16.13% | 17.38% | 16.73% | 18.61% | 17.30% | 18.47% | 15.82% | 18.05% | 17.58% | 19.06% | 17.31% | 19.17% |
| Other Income + | 4.65 | 2.77 | 3.40 | 6.07 | 9.01 | 8.81 | 11.13 | 5.54 | 10.23 | 7.51 | 2.93 | -10.20 | -18.32 |
| Interest | 25.63 | 25.55 | 26.89 | 29.46 | 26.84 | 33.71 | 35.98 | 40.70 | 44.17 | 45.47 | 43.62 | 44.78 | 42.70 |
| Depreciation | 42.20 | 41.01 | 43.21 | 44.16 | 45.98 | 47.01 | 49.74 | 56.52 | 58.07 | 57.91 | 62.80 | 60.65 | 62.81 |
| Profit before tax | 13.13 | 10.52 | 17.92 | 11.06 | 28.22 | 18.99 | 27.65 | -3.30 | 13.62 | 11.92 | 19.82 | -6.07 | 1.25 |
| Tax % | 56.97% | 65.30% | 39.84% | 68.99% | 16.87% | 28.23% | 25.21% | -334.85% | 50.29% | 49.83% | -4.24% | 30.15% | -223.20% |
| Net Profit + | 5.65 | 3.65 | 10.78 | 3.43 | 23.46 | 13.63 | 20.68 | 7.75 | 6.77 | 5.98 | 20.66 | -7.90 | 4.04 |
| EPS in Rs | 0.57 | 0.52 | 0.92 | 0.39 | 1.44 | 0.82 | 1.22 | 0.47 | 0.50 | 0.32 | 1.09 | -0.63 | 0.15 |
Financials of Healthcare Global Enterprises Ltd
Profit & Loss
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 519 | 584 | 700 | 829 | 976 | 1,092 | 1,009 | 1,395 | 1,691 | 1,908 | 2,218 | 2,545 |
| Expenses + | 443 | 499 | 595 | 713 | 864 | 936 | 887 | 1,161 | 1,394 | 1,581 | 1,835 | 2,080 |
| Operating Profit | 76 | 85 | 105 | 116 | 112 | 157 | 122 | 234 | 297 | 327 | 384 | 466 |
| OPM % | 15% | 15% | 15% | 14% | 11% | 14% | 12% | 17% | 18% | 17% | 17% | 18% |
| Other Income + | 0 | -2 | 10 | 25 | 10 | 10 | -72 | 110 | 15 | 24 | 39 | -18 |
| Interest | 34 | 38 | 23 | 42 | 70 | 138 | 119 | 98 | 104 | 109 | 155 | 177 |
| Depreciation | 39 | 44 | 57 | 71 | 85 | 148 | 159 | 158 | 163 | 174 | 211 | 244 |
| Profit before tax | 3 | 0 | 35 | 27 | -33 | -119 | -229 | 88 | 45 | 68 | 57 | 27 |
| Tax % | -56% | -730% | 34% | 38% | -7% | 5% | -3% | 56% | 61% | 39% | 14% | 15% |
| Net Profit + | 5 | 2 | 23 | 17 | -31 | -125 | -221 | 39 | 18 | 41 | 49 | 23 |
| EPS in Rs | 0.11 | -0.16 | 2.44 | 2.23 | -2.66 | -11.36 | -14.58 | 3.65 | 1.99 | 3.27 | 3.01 | 0.92 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Healthcare Global Enterprises Ltd
Balance Sheet
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 70 | 85 | 86 | 87 | 88 | 89 | 125 | 139 | 139 | 139 | 139 | 149 |
| Reserves | 210 | 341 | 347 | 428 | 389 | 293 | 572 | 731 | 721 | 686 | 783 | 1,183 |
| Borrowings + | 349 | 324 | 420 | 464 | 658 | 1,347 | 977 | 915 | 901 | 1,274 | 1,837 | 1,735 |
| Other Liabilities + | 147 | 294 | 372 | 461 | 515 | 518 | 357 | 433 | 549 | 601 | 780 | 855 |
| Total Liabilities | 776 | 1,043 | 1,225 | 1,440 | 1,650 | 2,246 | 2,031 | 2,218 | 2,311 | 2,701 | 3,540 | 3,923 |
| Fixed Assets + | 528 | 583 | 685 | 828 | 970 | 1,646 | 1,382 | 1,547 | 1,553 | 1,758 | 2,442 | 2,462 |
| CWIP | 42 | 121 | 148 | 174 | 153 | 46 | 30 | 22 | 18 | 83 | 25 | 19 |
| Investments | 0 | 64 | 11 | 53 | 49 | 34 | 26 | 9 | 10 | 10 | 11 | 14 |
| Other Assets + | 205 | 275 | 381 | 385 | 478 | 520 | 593 | 641 | 730 | 850 | 1,062 | 1,428 |
| Total Assets | 776 | 1,043 | 1,225 | 1,440 | 1,650 | 2,246 | 2,031 | 2,218 | 2,311 | 2,701 | 3,540 | 3,923 |
Financials of Healthcare Global Enterprises Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 60 | 73 | 91 | 98 | 98 | 130 | 121 | 220 | 252 | 285 | 317 | 347 |
| Cash from Investing Activity + | -79 | -204 | -210 | -283 | -238 | -101 | -171 | 125 | -133 | -226 | -488 | -177 |
| Cash from Financing Activity + | 22 | 216 | 89 | 161 | 84 | -58 | 112 | -155 | -140 | -64 | -42 | 241 |
| Net Cash Flow | 2 | 85 | -29 | -24 | -56 | -30 | 62 | 190 | -22 | -5 | -213 | 410 |
| Free Cash Flow | -20 | -137 | -101 | -158 | -90 | 23 | 85 | 150 | 126 | 101 | 110 | 59 |
| CFO/OP | 87% | 99% | 93% | 88% | 121% | 100% | 68% | 104% | 92% | 101% | 91% | 81% |
Financials of Healthcare Global Enterprises Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 45 | 43 | 54 | 57 | 59 | 62 | 67 | 57 | 65 | 56 | 66 | 60 |
| Inventory Days | 36 | 32 | 40 | 46 | 45 | 35 | 32 | 31 | 33 | 33 | 33 | 32 |
| Days Payable | 208 | 264 | 272 | 274 | 303 | 234 | 221 | 199 | 214 | 216 | 210 | 185 |
| Cash Conversion Cycle | -127 | -188 | -178 | -171 | -200 | -136 | -121 | -112 | -116 | -127 | -111 | -93 |
| Working Capital Days | -65 | -96 | -112 | -74 | -110 | -102 | -26 | -43 | -40 | -70 | -91 | -61 |
| ROCE % | 7% | 6% | 7% | 6% | 3% | 1% | -1% | 5% | 8% | 9% | 9% | 8% |
Guidance history
How Healthcare Global Enterprises Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 10–20% | Up 2%+ | Planned | Planned | — |
| Q4 FY26 call → | 10–20% | Up 0–2% | Planned | Planned | — |
| Q3 FY26 call → | 10–20% | Up 2%+ | Planned | Planned | — |
| Q2 FY26 call → | 10–20% | Up 2%+ | Planned | Planned | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
22 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −23.7% | 33% |
| Last 6 months | +2.3% | 59% |
| Last 3 months | −12.8% | 38% |
The price is 24.6% below its all-time high of ₹776.3 (29 Oct 2025). Stocks more than 20% below their peak have their score halved, so 44 became 22.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Healthcare Global Enterprises Ltd: 0.4 × 33 + 0.4 × 59 + 0.2 × 38 = 44, halved to 22 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Healthcare Global Enterprises Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
Others in Healthcare Services this season
- Rainbow Childrens Medicare Ltd (Q2 FY27)
Year-on-year (YoY) growth in revenue: 23.2% . Key investor presentation takeaways from Rainbow Childrens Medicare Ltd's Q2 FY27 investor presentation — and how
- Narayana Hrudayalaya Ltd (Q2 FY27)
Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27
- Artemis Medicare Services Ltd (Q2 FY27)
Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service
- Max Healthcare Institute Ltd (Q2 FY27)
Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio